IndiaTickerAnnual Report 2025 - Glenmark Pharmaceuticals ltdBSE · annual report · 412 pages
VerifiedArchived copy Company dossier
Glenmark Pharmaceuticals
NSE:GLENMARK · ISIN INE935A01035
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Glenmark Pharmaceuticals
Business
Business evidence pack
Source documentsPrimary material for understanding Glenmark Pharmaceuticals
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
Financial Year 2019 from bseBSE · annual report · 308 pages
VerifiedArchived copy Financial Year 2016 from bseBSE · annual report · 229 pages
VerifiedArchived copy Financial Year 2023 from bseBSE · annual report · 413 pages
VerifiedArchived copy Financial Year 2012 from bseBSE · annual report · 120 pages
VerifiedArchived copy Financial Year 2021 from bseBSE · annual report · 294 pages
VerifiedArchived copy Financial Year 2015 from bseBSE · annual report · 183 pages
VerifiedArchived copy Financial Year 2020 from bseBSE · annual report · 281 pages
VerifiedArchived copy Financial Year 2024 from bseBSE · annual report · 429 pages
VerifiedArchived copy Financial Year 2018 from bseBSE · annual report · 317 pages
VerifiedArchived copy Financial Year 2017 from bseBSE · annual report · 309 pages
VerifiedArchived copy Financial Year 2022 from bseBSE · annual report · 372 pages
VerifiedArchived copy Financial Year 2014 from bseBSE · annual report · 141 pages
VerifiedArchived copy Financial Year 2013 from bseBSE · annual report · 133 pages
VerifiedArchived copy Financial Year 2025 from bseBSE · annual report · 412 pages
VerifiedArchived copy